{"status": "Ok", "redirect_url": "https://www.cellectis.com/en/press/cellectis-receives-fda-rmat-designation-for-lasme-cel-the-first-allogeneic-car-t-therapy-in-a-pivotal-trial-for-patients-with-r-r-b-all/", "message": "News view counter 789822 successfully enlarged"}